Arrhythmogenicity of anti-tachycardia pacing programming parameters in patients with structural heart disease and implantable defibrillators

Main Article Content

Sherien Samy Awad

Keywords

VT acceleration – Ramp pacing- Scanning-Ventricular tachycardia- ATP therapy- ICD therapy .

Abstract

Background: Anti-tachycardia pacing therapy (ATP) is an effective, painless therapy for ventricular tachycardia (VT) termination. However, some patients experience VT acceleration that might degenerate into ventricular fibrillation (VF), leading to shock therapy. The aim of the study was to investigate the incidence of VT acceleration in patients with structural heart disease and implantable
defibrillators and its relation to the ATP programming parameters.
Methods: A total of 448 monomorphic VT episodes in 60 patients with structural heart disease and an ICD implant were reviewed after being retrieved from the programmers. The patients’ clinical data and the episodes’ details were analysed.
Results: ATP therapy was successful in terminating the VT in 70% of the analysed episodes. The incidence of VT acceleration in our studied patients was 8.5%. Patients with accelerated VT had a lower ejection fraction compared to patients with ATP-successful episodes. In the accelerated episodes, ramp pacing and scanning were frequently turned on. When VT-accelerated episodes were
compared to ATP-successful ones, the number of ATP bursts was higher and the adaptive cycle length was shorter.
Conclusions: Ventricular tachycardia acceleration by ATP therapy is likely to occur in patients with a severely impaired ejection fraction. Scanning, ramp pacing, and the number of ATP bursts delivered had a significant effect on VT acceleration. Scanning and ramp pacing are better to be turned off, and a lesser number of ATP bursts with a longer adaptive CL should be delivered.

Abstract 188 | pdf Downloads 126

References

1. Hindricks, Gerhard et al. “Prevention of sudden cardiac death by the implantable cardioverterdefibrillator.” Polish archives of internal
medicine vol. 128,12 (2018): 764-770. doi:10.20452/pamw.4386
2. Wathen, Mark. “Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.” American
heart journal vol. 153,4 Suppl (2007): 44-52. doi:10.1016/j.ahj.2007.01.020
3. Freedenberg, Vicki et al. “Anxiety and depression in implanted cardioverter-defibrillator recipients and heart failure: a review.” Heart failure clinics vol. 7,1 (2011): 59-68. doi:10.1016/j.hfc.2010.08.008
4. Stevenson WG. Ventricular scars and ventricular tachycardia. Trans Am Clin Climatol Assoc. 2009;120:403-12. PMID: 19768192; PMCID:
PMC2744510
5. Pokorney, Sean D, and Sana M Al-Khatib. “Management of pace-terminated ventricular arrhythmias.” Cardiac electrophysiology clinics vol. 7,3 (2015): 497-513. doi:10.1016/j.ccep.2015.05.009
6. De Maria E, Giacopelli D, Borghi A, Modonesi L, Cappelli S. Antitachycardia pacing programming in implantable cardioverter
defibrillator: A systematic review. World J Cardiol. 2017 May 26;9(5):429-436. doi: 10.4330/wjc.v9.i5.429. PMID: 28603590; PMCID: PMC5442411
7. Sweeney, Michael O. “Antitachycardia pacing for ventricular tachycardia using implantable cardioverter defibrillators:.” Pacing and clinical electrophysiology : PACE vol. 27,9 (2004): 1292-305. doi:10.1111/j.1540- 8159.2004.00622.x
8. Lee, Douglas S et al. “Effectiveness of implantable defibrillators for preventing arrhythmic events and death: a metaanalysis.” Journal of the American College of Cardiology vol. 41,9 (2003): 1573-82. doi:10.1016/s0735-1097(03)00253-5
9. Sears SF Jr, Conti JB. Quality of life and psychological functioning of icd patients. Heart. 2002 May;87(5):488-93. doi: 10.1136/heart.87.5.488. PMID: 11997430; PMCID: PMC1767118
10. Wathen, Mark. “Implantable cardioverter defibrillator shock reduction using new antitachycardia pacing therapies.” American
heart journal vol. 153,4 Suppl (2007): 44-52. doi:10.1016/j.ahj.2007.01.020
11. Calkins H, El‐Atassi R, Kalbfleisch S, Langberg J, Morady F (1993) Comparison of Fixed Burst Versus Decremental Burst Pacing for
Termination of Ventricular Tachycardia. Pacing Clin Electrophysiol 16(1):26–32. https://doi.org/10.1111/j.1540- 8159.1993.tb01531.x
12. Newman D, Dorian P, Hardy J (1993) Randomized controlled comparison of antitachycardia pacing algorithms for termination
of ventricular tachycardia. J Am Coll Cardiol 21(6):1413–1418. https://doi.org/10.1016/0735- 1097(93)90318-U
13. Gillis AM, Leitch JW, Sheldon RS, Morillo CA, Wyse DG, Yee R, Klein GJ, Mitchell LB (1993) A prospective randomized comparison of
autodecremental pacing to burst pacing in device therapy for chronic ventricular tachycardia secondary to coronary artery disease. Am J
Cardiol 72(15):1146–1151. https://doi.org/10.1016/0002-9149(93)90984-K
14. Kantoch MJ, Green MS, Tang ASL (1993) Randomized Cross‐Over Evaluation of Two Adaptive Pacing Algorithms for the Termination
of Ventricular Tachycardia. Pacing Clin Electrophysiol 16(8):1664–1672. https://doi.org/10.1111/j.1540- 8159.1993.tb01037.x
15. Hammill SC, Packer DL, Stanton MS, Fetter J (1995a) Termination and Acceleration of Ventricular Tachycardia with Autodecremental
Pacing, Burst Pacing, and Cardioversion in Patients with an Implantable Cardioverter Defibrillator. Pacing Clin Electrophysiol
18(1):3–18. https://doi.org/10.1111/j.1540- 8159.1995.tb02469.x
16. Peters RW, Zhang X, Gold MR (2001) Clinical predictors and efficacy of antitachycardia pacing in patients with implantable cardioverter defibrillators: the importance of the patient’s sex. Pacing Clin Electrophysiol 24(1):70–74. https://doi.org/10.1046/J.1460-
9592.2001.00070.X
17. Santini M, Lunati M, Defaye P, Mermi J, Proclemer A, Del Castillo-Arroys S, Molon G, Santi E, De Santo T, Navarro X, Kloppe A
(2010a) Prospective multicenter randomized trial of fast ventricular tachycardia termination by prolonged versus conventional antitachyarrhythmia burst pacing in implantable cardioverter-defibrillator patients-Atp deliVery for pAiNless ICD thErapy (ADVANCE-D) trial results. J Interv Card Electrophysiol 27(2):127– 135. https://doi.org/10.1007/s10840-009-9454-z
18. Fang Y, Gu K, Yang B, Ju W, Chen H, Li M, Liu H, Wang J, Yang G, Chen M (2018) What factors lead to the acceleration of ventricular tachycardia during antitachycardia pacing?—Results from over 1000 episodes. J Arrhythmia 34(1):36.https://doi.org/10.1002/JOA3.12010